Advertisement
Join us for an insightful medical symposium featuring Prof. Axel Dignass (Goethe University, Germany) and chaired by Dr. Joyce Mak (Hong Kong IBD Society) as we delve into the latest developments in Inflammatory Bowel Disease management. 💡 Key Topics & Learning Objectives:
- The evolution of IBD treatment goals from symptom control toward deep healing and disease modification
- Evidence for guselkumab across UC and CD, including efficacy, safety, and emerging evidence in perianal fistulizing CD
- How patient characteristics and evidence inform the positioning of IL-23 inhibition in treatment-naive and difficult-to-treat patients
📅 Date: Wednesday, 11 November 2026
⏰ Time: 19:00 – 20:30 HKT
📍 Location: Hyatt Regency, Tsim Sha Tsui
📜 CME Accreditation: Pending
🔒 Please Note: This event is by invitation only and strictly reserved for healthcare professionals for on-site participation.
📧 For enquiries or further information, please contact Mr. Jimmy Li at [email protected].
Co-organized by Hong Kong IBD Society & Johnson & Johnson
Advertisement
Event venue
Hyatt Regency Hong Kong, Tsim Sha Tsui, 18 Hanoi Road, Tsim Sha Tsui, Kowloon, Hong Kong (sar)
Tickets